Kramer, M.D.

patient cancer tumor pai -2 breast level prognostic group breast cancer model plasminogen 0.0001 status system urokinase factor node-positive patients protein analysis upa system prognosis activator multivariate receptor urokinase system urokinase-type plasminogen activator nodal status menopausal status prognostic factors tumor size adjuvant therapy node-negative inhibitor component variable prognostic score table pai -2 levels node-positive therapy node-negative patients value plasminogen activation multivariate model number adjuvant score 2780 patients nodal analyses urokinase receptor risk groups result function urokinase plasminogen activator menopausal prognostic value plasminogen activator inhibitor cytosol tissue relationship grade /pgr status janicke multivariate analysis point 10 years migration brunner activation assay 1995. follow-up breast cancer patients tumor cell adhesion failures /total number foeken urokinase-type breast cancer res lymph node status